Evidence map›Paper›PMID 36979763›Full record

ArticleBiomedicines2023

Novel Variant of the

Dżamila M Bogusławska, Sebastian Kraszewski, Michał Skulski, Stanisław Potoczek, Kazimierz Kuliczkowski, Aleksander F Sikorski

Open access · goldFull text read
In one paragraph

Article in Biomedicines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Expanding the genetic landscape ofFrontiers in genetics · 2026
    Article
  2. Article
  3. Two Variants of theBiomedicines · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 1 country.

Dżamila M BogusławskaDepartment of Biotechnology, Institute of Biological Sciences, University of Zielona Góra, Prof. Szafrana St. 1, 65-516 Zielona Góra, Poland.ORCID 0000-0001-9270-7510
Sebastian KraszewskiDepartment of Biomedical Engineering, Wroclaw University of Science and Technology, Plac Grunwaldzki 13 (D-1), 50-377 Wroclaw, Poland.ORCID 0000-0003-3244-7694
Michał SkulskiDepartment of Cytobiochemistry, Faculty of Biotechnology, University of Wroclaw, F. Joliot-Curie 14a St., 50-383 Wroclaw, Poland.ORCID 0000-0002-9609-2979
Stanisław PotoczekDepartment and Clinic of Haematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw Medical University, Wybrzeże L. Pasteura 4, 50-367 Wroclaw, Poland.
Kazimierz KuliczkowskiSilesian Park of Medical Technology Kardio-Med Silesia, ul. M. Curie-Skłodowskiej 10c, 41-800 Zabrze, Poland.
Aleksander F SikorskiResearch and Development Centre, Regional Specialist Hospital, Kamieńskiego 73a, 51-154 Wroclaw, Poland.ORCID 0000-0003-3779-8266
Kardio-Med Silesia · PLUniversity of Wrocław · PLUniversity of Zielona Góra · PLWroclaw Medical University · PLWroclaw Research Centre EIT+ (Poland) · PLWrocław University of Science and Technology · PL

Funding

National Science Center 2015/19/B/NZ5/03469
6 · The paper itself

Abstract

Hereditary spherocytosis (HS) refers to the group of the most frequently occurring non-immune hereditary hemolytic anemia in people of Caucasian central or northern European ancestry. HS is mainly associated with pathogenic variants of genes encoding defects in five membrane proteins, including anion exchanger 1 encoded by the

Indexed as

anion exchanger 1erythrocyte membrane proteinhereditary spherocytosismolecular dynamics simulationwhole exome sequencing

Identifiers

PMID36979763
PMCPMC10045460
OpenAlexW4323311856

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read27
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.